STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells <i>in vitro</i>
2009 · International Journal of Cancer · 70 citations
https://doi.org/10.1002/ijc.24567
B
Bo Hong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
2.2K
Citations
27
h-index
61
i10-index
Bo Hong is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Cancer Research and Treatments & Cancer Immunotherapy and Biomarkers & RNA modifications and cancer. The author has an h-index of 27, co-authored 95 publications.
ORCID: 0000-0001-8117-5029Papers by this author
worksCirculating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
2020 · Scientific Reports · 27 citations
https://doi.org/10.1038/s41598-020-69615-6
Dihydroquercetin composite nanofibrous membrane prevents UVA radiation-mediated inflammation, apoptosis and oxidative stress by modulating MAPKs/Nrf2 signaling in human epidermal keratinocytes
2022 · Biomedicine & Pharmacotherapy · 22 citations
https://doi.org/10.1016/j.biopha.2022.113727
B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
2022 · BMC Cancer · 17 citations
https://doi.org/10.1186/s12885-022-10159-5
Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer
2024 · iScience · 5 citations
https://doi.org/10.1016/j.isci.2024.110413
Additional file 1 of Characterization of genomic instability-related genes predicts survival and therapeutic response in lung adenocarcinoma
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24580299
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat